On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
In this first alert of the decade, African Centre of Biodiversity research and advocacy officers Linzi Lewis and Sabrina Masinjila provide an update on the status of GM activities, in South Africa and in relation to the region.
The African Centre for Biodiversity (ACB) is extremely alarmed to learn that three genetically modified maize varieties developed by Corteva (new name of the Dow-DuPont merged entity) to withstand the application of the dangerous 2,4-D herbicide have been approved for general release by the Executiv
Resounding no to Monsanto’s ‘bogus’ GM drought tolerant maize: South Africa’s Minister, Appeal Board and Biosafety Authority Reject Monsanto’s GM seeds
Johannesburg, South Africa, 4 October 2019
Civil society organisations and citizens across Africa are calling upon their governments to issue an immediate ban on all use of glyphosate and glyphosate-based herbicides (GBHs).
6 September 2019
The African Centre for Biodiversity (ACB) is extremely concerned about impending approvals by the South African government in regard to three new genetically modified (GM) maize varieties designed to withstand the extremely toxic herbicide, 2,4-D.
Thank you for supporting our continental campaign to ban glyphosate
ACB’s Objection to Monsanto’s Application for Commodity Import of GM maize for a number of events: herbicide tolerance, including for dicamba, as well as pest resistance -
MON 87427 x MON 89034 x MIR 162 x MON87419;
We, the undersigned civil society organisations in Africa, hereby call upon the Bill and Melinda Gates Foundation and the Target Malaria project to stop the intended release of 10 000 genetically modified (GM) “male sterile” mosquitoes in Burkina Faso, as the release poses unacceptable risks to human beings and the environment.
A decade ago, genetically modified (GM) mosquitoes were first released globally, in the Cayman Islands, by UK-based company Oxitec. Further releases followed in Malaysia, Panama and Brazil.
The ACB shares with you a blog written by ACB’s Sabrina Masinjila and KBIOC’s Anne Maina *
On the pretext of supporting scientific innovation for malaria eradication, African countries vociferously defended a techno-fix that does not address the wider determinants of malaria – but rather, represents the changing face of colonial medicine and threatens the biodiversity of an entire continent.
African farmers are demanding that Lynas cease using their images in his GMO promotionals; Lynas’s mischief-making may have triggered Tanzania’s ending of GMO field trials. Report: Claire Robinson, GMWatch and Mariam Mayet, African Centre for Biodiversity